TrialThe Journal of experimental medicine2020

Autologous tumor cell vaccine induces antitumor T cell immune responses in patients with mantle cell lymphoma: A phase I/II trial.

Matthew J Frank et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.